Literature DB >> 32885529

Stratum corneum lipidomics analysis reveals altered ceramide profile in atopic dermatitis patients across body sites with correlated changes in skin microbiome.

Hila Emmert1, Hansjörg Baurecht1,2, Frederieke Thielking1, Dora Stölzl1, Elke Rodriguez1, Inken Harder1, Ehrhardt Proksch1, Stephan Weidinger1.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is driven by the interplay between a dysfunctional epidermal barrier and a skewed cutaneous immune dysregulation. As part of the complex skin barrier dysfunction, abnormalities in lipid organization and microbiome composition have been described. We set out to systematically investigate the composition of the stratum corneum lipidome, skin microbiome and skin physiology parameters at three different body sites in patients with AD and healthy volunteers.
METHODS: We analysed tape strips from different body areas obtained from 10 adults with AD and 10 healthy volunteers matched for FLG mutation status for 361 skin lipid species using the Metabolon mass spectrometry platform. 16S rRNA data were available from all probands.
RESULTS: Our study showed that the lipid composition differs significantly between body sites and between AD patients and healthy individuals. Ceramide species NS was significantly higher in AD patients compared to healthy volunteers and was also higher in AD patients with a FLG mutation compared to AD patients without a FLG mutation. The correlation analysis of skin lipid alterations with the microbiome showed that Staphylococcus colonization in AD is positively correlated with ceramide subspecies AS, ADS, NS and NDS.
CONCLUSION: This is the first study to reveal site-specific lipid alterations and correlations with the skin microbiome in AD.
© 2020 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Atopic dermatitis; Filaggrin; lipidome; metabolomics

Mesh:

Substances:

Year:  2020        PMID: 32885529     DOI: 10.1111/exd.14185

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

Review 1.  Skin barrier dysfunction and filaggrin.

Authors:  Yeonjoon Kim; Kyung-Min Lim
Journal:  Arch Pharm Res       Date:  2021-01-18       Impact factor: 4.946

Review 2.  An Overview of the Latest Metabolomics Studies on Atopic Eczema with New Directions for Study.

Authors:  Jamie Afghani; Claudia Traidl-Hoffmann; Philippe Schmitt-Kopplin; Matthias Reiger; Constanze Mueller
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

3.  Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.

Authors:  Sanja Kezic; Maeve A McAleer; Ivone Jakasa; Susan M I Goorden; Karen Ghauharali-van der Vlugt; Femke S Beers-Stet; Judith Meijer; Jeroen Roelofsen; Monique M Nieman; André B P van Kuilenburg; Alan D Irvine
Journal:  Br J Dermatol       Date:  2022-04-05       Impact factor: 11.113

Review 4.  Current Knowledge in Skin Metabolomics: Updates from Literature Review.

Authors:  Alessia Paganelli; Valeria Righi; Elisabetta Tarentini; Cristina Magnoni
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

5.  Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes.

Authors:  Alexander A Merleev; Stephanie T Le; Claire Alexanian; Atrin Toussi; Yixuan Xie; Alina I Marusina; Steven M Watkins; Forum Patel; Allison C Billi; Julie Wiedemann; Yoshihiro Izumiya; Ashish Kumar; Ranjitha Uppala; J Michelle Kahlenberg; Fu-Tong Liu; Iannis E Adamopoulos; Elizabeth A Wang; Chelsea Ma; Michelle Y Cheng; Halani Xiong; Amanda Kirane; Guillaume Luxardi; Bogi Andersen; Lam C Tsoi; Carlito B Lebrilla; Johann E Gudjonsson; Emanual Maverakis
Journal:  JCI Insight       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.